Researchers from the University of Valencia have developed a gas chromatography-drift tube ion mobility spectrometry (GC–IMS) method for the analysis of illicit and psychoactive substances in oral fluids (1).
The determination of illicit drugs is needed across many industries, from toxicology reports in hospitals to traffic control or doping prevention in professional sports. Traditionally these determinations have been carried out through the analysis of urine and blood; however, each have issues associated with them. In the case of blood, the sampling procedure is quite invasive, whereas with urine there have been numerous incidents of falsification. Therefore, interest in alternative biological fluids has increased, with oral fluids emerging as one such target. The main advantages of oral fluids are the non-invasive sampling and the potential analysis of unmetabolized drugs.
Another important consideration is the technique used to analyze the oral fluids. Hyphenated mass spectrometry techniques, and especially liquid chromatography (LC)–MS/MS, have gained in popularity because of their selectivity, specificity, and sensitivity, but they require expensive instrumentation not accessible to all laboratories. Solid-phase extraction (SPE) or liquid-phase microextraction (LPME) followed by LC–MS and GC–MS are also possibilities, requiring slightly more in terms of sample preparation than the proposed method, which utilized a simple centrifugation step prior to injection.
Other limitations of GC–IMS were acknowledged by the researchers in terms of the method’s ability to identify unknown signals. There are no global available databases for the reduced ion mobility constants (K0), and therefore, for unequivocal identification, the MS spectra should be verified. This could be a major drawback to the method’s acceptance by possible end users. However, researchers also point to a recent database of K0 values that has been published with approximately 200 psychoactive compounds, including illicit and new psychoactive substances (2), which could be used to obtain preliminary information regarding unknown substances.
As such, researchers wanted to explore the possibility of utilizing GC–IMS to determine illicit and psychoactive substances in oral fluids. Amphetamine, methylone, α-PVP, ketamine, lidocaine, MPHP, cocaine, THJ-2201, and 5F-ADB were employed as model compounds in the study. The developed method was tested through the analysis of two oral fluid certified reference materials, with the obtained relative percentage errors lower than 8.4%. This indicated that the proposed GC–IMS procedure could be a reliable, selective, and sensitive technique for the determination of psychoactive substances in oral fluids.
References
An LC–HRMS Method for Separation and Identification of Hemoglobin Variant Subunits
March 6th 2025Researchers from Stanford University’s School of Medicine and Stanford Health Care report the development of a liquid chromatography high-resolution mass spectrometry (LC–HRMS) method for identifying hemoglobin (Hb) variants. The method can effectively separate several pairs of normal and variant Hb subunits with mass shifts of less than 1 Da and accurately identify them in intact-protein and top-down analyses.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.